Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06650228

Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis

A review of the literature did not identify any studies that assessed knowledge of cardiovascular disease risk factors and healthy lifestyle behaviours in patients with ankylosing spondylitis. The aim of this study is to assess knowledge of cardiovascular disease risk factors, healthy lifestyle behaviours and physical activity levels in patients with ankylosing spondylitis.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ankylosing Spondylitis (AS) Ankylosis Arthritis Axial Spondyloarthritis Bone Diseases Joint Diseases Musculoskeletal Diseases Spinal Diseases Spondylarthritis Spondylarthropathies Spondylitis Spondylitis, Ankylosing

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kirsehir Ahi Evran University

Kırşehir, Turkey (Türkiye)

Location status: Recruiting

Location contact

Merve Firat, Assistant Professor

CONTACT

[email protected]

+90 850 441 02 44

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of ankylosing spondylitis according to ASAS diagnostic criteria
  • Being aged 18-65
  • Stable medication use for at least 3 months
  • Voluntary participation in the study

Exclusion criteria

  • Having uncontrolled cardiopulmonary disease
  • Being pregnant
  • Having undergone recent surgery
  • Presence of malignancy

Treatment and study plan

Primary outcomes

  1. Knowledge of cardiovascular disease risk factors

    Time frame: 10 minutes

    This will be evaluated using The Cardiovascular Disease Risk Factors Knowledge Level scale. The maximum score that can be obtained from the 28-question scale is 28.Higher scores on the scale indicate better knowledge of cardiovascular disease.

  2. Healthy lifestyle behaviors

    Time frame: 15 minutes

    It will be evaluated with the Healthy Lifestyle Behaviors scale II.The lowest score on the whole scale is 52 and the highest is 208. As the score obtained from the survey increases, it is assumed that the participant's level of healthy lifestyle behaviour is high.

Secondary outcomes

  1. Physical activity

    Time frame: 5 minutes

    Physical activity level will be evaluated using International Physical Activity Questionnaire-Short form

  2. Cardiovascular risk

    Time frame: 5 minutes

    The Framingham Risk Score will be calculated to determine cardiovascular risk. Framingham risk score; if the estimated risk of cardiovascular events is above 10%, the risk is considered high; if it is below 10%, the risk is considered low.

  3. Comorbidity

    Time frame: 5 minutes

    Comorbidity level will be evaluated with the Charlson Comorbidity Index

Study contacts

Contact information is provided by the study sponsor or research team.

Merve Firat

CONTACT

[email protected]

+90 850 441 02 44 ext. 2490

Sponsors and collaborators

Lead sponsor

Kirsehir Ahi Evran Universitesi

Other

Registry information

Official study title

Assessment of Knowledge of Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 21, 2024
Registry last updated
Oct 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.